Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 58 articles:
HTML format
Text format



Single Articles


    December 2017
  1. CAMPBELL B, Lopez A, Liu B, Bhuket T, et al
    A Pilot Program Integrating Hepatitis B Virus (HBV) Screening into an Outpatient Endoscopy Unit Improves HBV Screening Among an Ethnically Diverse Safety-Net Hospital.
    Dig Dis Sci. 2017 Dec 5. pii: 10.1007/s10620-017-4870.
    PubMed     Text format     Abstract available


  2. HOVAIDA M, Torrazza-Perez E, McCarthy D
    Liver Function Tests "Gone Viral": Acute Hepatitis of Uncertain Cause.
    Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4849.
    PubMed     Text format    


    November 2017
  3. KWAK YE, Stein SM, Lim JK
    Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.
    Dig Dis Sci. 2017 Nov 24. pii: 10.1007/s10620-017-4850.
    PubMed     Text format     Abstract available


    October 2017
  4. BOSCARINO JA, Moorman AC, Rupp LB, Zhou Y, et al
    Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution.
    Dig Dis Sci. 2017;62:2704-2712.
    PubMed     Text format     Abstract available


    September 2017
  5. XING J, Spradling PR, Moorman AC, Holmberg SD, et al
    A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Sep 30. doi: 10.1007/s10620-017-4762.
    PubMed     Text format     Abstract available


  6. PARIKH ND, Fu S, Rao H, Yang M, et al
    Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4776.
    PubMed     Text format     Abstract available


  7. HOSSAIN N, Puchakayala B, Kanwar P, Verma S, et al
    Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
    Dig Dis Sci. 2017 Sep 14. doi: 10.1007/s10620-017-4754.
    PubMed     Text format     Abstract available


  8. CHAN J, Gogela N, Zheng H, Lammert S, et al
    Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment.
    Dig Dis Sci. 2017 Sep 8. doi: 10.1007/s10620-017-4749.
    PubMed     Text format     Abstract available


  9. IKEDA K, Kawamura Y, Kobayashi M, Kominami Y, et al
    Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4739.
    PubMed     Text format     Abstract available


  10. PURNAK T, Efe C, Kav T, Wahlin S, et al
    Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.
    Dig Dis Sci. 2017 Sep 4. doi: 10.1007/s10620-017-4728.
    PubMed     Text format     Abstract available


  11. DU JEONG I, Jung SW, Park BR, Lee BU, et al
    Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naive Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2017 Sep 4. doi: 10.1007/s10620-017-4737.
    PubMed     Text format     Abstract available


    August 2017
  12. YAYA I, Roux P, Marcellin F, Salmon-Ceron D, et al
    Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).
    Dig Dis Sci. 2017 Aug 5. doi: 10.1007/s10620-017-4703.
    PubMed     Text format    


    July 2017
  13. CZAJA AJ
    Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.
    Dig Dis Sci. 2017 Jul 14. doi: 10.1007/s10620-017-4675.
    PubMed     Text format     Abstract available


    June 2017
  14. AFSARI A, Lee E, Shokrani B, Boortalary T, et al
    Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Jun 13. doi: 10.1007/s10620-017-4626.
    PubMed     Text format     Abstract available


  15. WU E, Yang M, Rao H, Fu S, et al
    Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China.
    Dig Dis Sci. 2017 Jun 1. doi: 10.1007/s10620-017-4619.
    PubMed     Text format     Abstract available


    May 2017
  16. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    PubMed     Text format     Abstract available


  17. LENCI I, Bosa A, Milana M, Baiocchi L, et al
    Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation.
    Dig Dis Sci. 2017 May 12. doi: 10.1007/s10620-017-4594.
    PubMed     Text format    


    April 2017
  18. DEVER JB, Ducom JH, Ma A, Nguyen J, et al
    Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.
    Dig Dis Sci. 2017 Apr 4. doi: 10.1007/s10620-017-4548.
    PubMed     Text format     Abstract available


    March 2017
  19. OMINO R, Mittal S, Kramer JR, Chayanupatkul M, et al
    The Validity of HCC Diagnosis Codes in Chronic Hepatitis B Patients in the Veterans Health Administration.
    Dig Dis Sci. 2017 Mar 7. doi: 10.1007/s10620-017-4503.
    PubMed     Text format     Abstract available


    February 2017
  20. AHN J, Liu B, Bhuket T, Wong RJ, et al
    Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
    Dig Dis Sci. 2017 Feb 6. doi: 10.1007/s10620-017-4469.
    PubMed     Text format     Abstract available


  21. DURAISWAMY S, Sheffield JS, Mcintire D, Leveno K, et al
    Updated Etiology and Significance of Elevated Bilirubin During Pregnancy: Changes Parallel Shift in Demographics and Vaccination Status.
    Dig Dis Sci. 2017;62:517-525.
    PubMed     Text format     Abstract available


    January 2017
  22. SHALIMAR, Kedia S, Gunjan D, Sonika U, et al
    Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients.
    Dig Dis Sci. 2017 Jan 27. doi: 10.1007/s10620-017-4461.
    PubMed     Text format     Abstract available


  23. RIVEIRO-BARCIELA M, Tabernero D, Calleja JL, Lens S, et al
    Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Jan 11. doi: 10.1007/s10620-017-4448.
    PubMed     Text format     Abstract available


  24. AGORAMOORTHY G
    India Needs Effective Surveillance to Control Hepatitis C.
    Dig Dis Sci. 2017 Jan 3. doi: 10.1007/s10620-016-4436.
    PubMed     Text format    


  25. DELLA-GUARDIA B, Evangelista AS, Felga GE, Marins LV, et al
    Diagnostic Accuracy of Transient Elastography for Detecting Liver Fibrosis After Liver Trannsplantation: A Specific Cut-Off Value Is Really Needed?
    Dig Dis Sci. 2017;62:264-272.
    PubMed     Text format     Abstract available


    December 2016
  26. KIM EJ, Yeon JE, Kwon OS, Lee HN, et al
    Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4431.
    PubMed     Text format     Abstract available


    October 2016
  27. BECK KR, Kim N, Khalili M
    Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  28. ASSIS DN, Takahashi H, Leng L, Zeniya M, et al
    A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    September 2016
  29. NATARAJAN Y, White DL, El-Serag HB, Ramsey D, et al
    Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  30. HE QF, Zhang QF, Zhang DZ
    Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  31. FOX R
    Going Viral: Why Eliminating the Burden of Hepatitis C Requires Enhanced Cooperation Between Specialists and Primary Care Providers.
    Dig Dis Sci. 2016.
    PubMed     Text format    


    August 2016
  32. FOSTER MA, Xing J, Moorman AC, Boscarino J, et al
    Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    July 2016
  33. WEILER-NORMANN C, Lohse AW
    Nonalcoholic Fatty Liver Disease in Patients with Autoimmune Hepatitis: Further Reason for Teeth GNASHing?
    Dig Dis Sci. 2016.
    PubMed     Text format    


  34. MONTANO-LOZA AJ, Thandassery RB, Czaja AJ
    Targeting Hepatic Fibrosis in Autoimmune Hepatitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  35. CZAJA AJ
    Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    June 2016
  36. SCLAIR SN, Carrasquillo O, Czul F, Trivella JP, et al
    Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  37. DE LUCA-JOHNSON J, Wangensteen KJ, Hanson J, Krawitt E, et al
    Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    May 2016
  38. CHAK EW, Sarkar S, Bowlus C
    Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  39. MOORMAN AC, Tong X, Spradling PR, Rupp LB, et al
    Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS).
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    April 2016
  40. LIN XJ, Lao XM, Shi M, Li SP, et al
    Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  41. CHOLANKERIL G, Perumpail RB, Hu M, Skowron G, et al
    Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  42. REICH JS, Farraye FA, Wasan SK
    Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  43. COZEN ML, Ryan JC, Shen H, Cheung R, et al
    Improved Survival Among all Interferon-alpha-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  44. JHA LK, Gilbert J
    Treatment of Dual Genotype Chronic Hepatitis C: Case Series.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  45. PECTASIDES E, Miksad R, Pyatibrat S, Srivastava A, et al
    Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    March 2016
  46. BURMAN BE, Bacchetti P, Khalili M
    Moderate Alcohol Use and Insulin Action in Chronic Hepatitis C Infection.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  47. PAUL S, Shuja A, Tam I, Kim EM, et al
    Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  48. THOMSON M, Konerman MA, Choxi H, Lok AS, et al
    Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    February 2016
  49. PATIDAR KR, Bajaj JS
    Tired of Hepatitis B?
    Dig Dis Sci. 2016.
    PubMed     Text format    


    January 2016
  50. EVON DM, Wahed AS, Johnson G, Khalili M, et al
    Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN).
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  51. MARCELLIN P, Zoulim F, Hezode C, Causse X, et al
    Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  52. RUBIN JN, Te HS
    Refractory Autoimmune Hepatitis: Beyond Standard Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  53. FLEMMING JA, Saxena V, Shen H, Terrault NA, et al
    Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA.
    Dig Dis Sci. 2016;61:62-9.
    PubMed     Text format     Abstract available


    December 2015
  54. DYAL HK, Aguilar M, Bartos G, Holt EW, et al
    Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  55. DOU CY, Fan YC, Cao CJ, Yang Y, et al
    Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  56. URIBE LA, Nguyen N, Kim L, Trinh HN, et al
    Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    November 2015
  57. PETERSEN J, Heyne R, Mauss S, Schlaak J, et al
    Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    July 2015
  58. RAVI S, Shoreibah M, Raff E, Bloomer J, et al
    Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: